Article
Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs.
Oncotarget - 21 Feb 2017
Zhu Yan-Juan, Zhang Hai-Bo, Liu Yi-Hong, Zhang Fu-Li, Zhu Ya-Zhen, Li Yong, Bai Jian-Ping, Liu Li-Rong, Qu Yan-Chun, Qu Xin, Chen Xian, Li Yan, Zheng Guang-Juan
Abstract excerpt
Detection of circulating tumor DNA using droplet digital polymerase chain reaction (ddPCR) is a highly-sensitive, minimally invasive alternative to serial biopsies for assessment and management of cancer. We used ddPCR to assess the utility of measuring plasma concentrations of common epidermal growth factor receptor (EGFR) mutations (L858R, exon 19 deletion, and T790M) in 57 non-small cell lung cancer (NSCLC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
